|
|
| Breast Cancer Information |
|
|
Early Breast Cancer Detection
Most women are familiar with mammography as our "gold standard" for breast cancer screening. However, there are additional tools available that women can add to their arsenal. One of the most effective tools in breast cancer screening is breast self-exam (BSE). However, BSE works best when women are appropriately trained in the procedure, and then followed-up with annual clinical breast exams (CBE) from their physicians. In a 2000 University of Toronto study, approximately 20,000 women were screened for breast cancer with BSE and annual CBE, and 20,000 were screened with BSE and mammograms. After more than 10 years, the BSE and annual CBE reported 610 cases of invasive breast cancer, and 105 deaths. In the BSE and mammogram group, there were 622 cases of invasive breast cancer and 107 deaths. Without question, the first line of defense against breast cancer begins with diligent BSE. Other tools that are available to women include the AMAS (anti-malignan antibody screen) test and the NMP Nuclear matrix protein) test. Both these are blood tests that measure a certain protein in the blood that may indicate cancer. The AMAS test has been around for several years while the NMP test has not been available until only recently. Clinical trials continue in this area. One additional tool that may detect an issue early is digital infrared thermal imaging or DITI. In 1982, the FDA approved thermography as an adjunctive tool for breast cancer screening. DITI measures heat emitted from the body and is accurate to 1/100th of a degree. DITI examines physiology, NOT structure. It is in this capacity that DITI can monitor breast HEALTH over time and alert a patient or physician to a developing problem; possibly before a lump can be seen on X-ray or palpated clinically. There are no test limitations such as breast density. DITI is a non-invasive test that does not emit radiation. The unique characteristics of cancer allow DITI to detect breast cancer at an earlier stage of growth. As cancer is developing, it builds its own blood supply which is then reflected as increased heat in that particular region of the breast. DITI has a specificity of 83%; which reflects a problem in its early stages of development not late-stage cancer as in mammography. An abnormal thermogram carries a 10-times greater risk for cancer and a persistently abnormal thermogram carries a 22-times greater risk for cancer. Clinical research studies continue to support thermography's role as an adjunctive tool in breast cancer screening and the ONLY tool that measures breast health over time. There are now more than 800 publications on over 300,000 women in clinical trials. A recent finding published in the American Journal of Radiology in 2003 showed that thermography has 99% sensitivity in identifying breast cancer with single examinations and limited views. Scientists concluded that a negative thermogram is powerful evidence that cancer is not present. Thermographic screening is not covered by most insurance companies but is surprisingly affordable for most people. For more information or to find a certified clinic in your area, go to www.proactivehealthonline.com. Brenda Witt is co-owner of Proactive Health Solutions in Southern California. She is an American College of Clinical Thermology (ACCT) certified thermographer in the Orange County area.
MORE RESOURCES: Breastfeeding for at least six months might lower the risk of developing so-called "triple negative" breast cancer, an aggressive form of the disease that is more common in black and younger women, according to a study published on Monday in the journal Cancer, the Seattle Post-Intelligencer reports (Paulson, Seattle Post-Intelligencer, 8/24). A new promising enzyme target for a specific type of breast cancer, Brk, has been identified in research published on August 21, 2008 in the Proceedings of the National Academy of Sciences (PNAS.) In a specific subset of breast cancer patients, the tumor cells produce high levels of the protein ErbB2 (also called HER2) which pushes the cells to proliferate without limit, a characteristic common of all cancers. The American Medical Student Association (AMSA), the nation's oldest and largest, independent association for physicians-in-training, announces the commencement of AMSA Academy, a training ground for physician leaders. Established by students, for students, AMSA Academy takes medical students through the core competencies of leadership and project implementation, while building on key principles of important topics in medicine. There are currently 22 programs offered. Happiness and optimism may play a role against breast cancer while adverse life events can increase the risk of developing the disease, according to a study by Professor Ronit Peled, at Ben-Gurion University of the Negev in Israel. An article on the study titled "Breast Cancer, Psychological Distress and Life Events among Young Women," was just published in the British journal BMC Cancer (8:245, August 2008). Feelings of happiness and optimism play a positive role against breast cancer. Research published in the open access journal BMC Cancer suggests that while staying positive has a protective role, adverse life events such as the loss of a parent or close relative, divorce or the loss of a spouse can increase a woman's risk of developing the disease. New research may explain why breast cancer tends to be more aggressive in women with denser breast tissue. Breast cancer cells grown in dense, rigid surroundings step up their invasive activities, Vanderbilt-Ingram Cancer Center investigators report in the Sept. 9 issue of Current Biology. The findings suggest a cellular mechanism for the correlation between human breast tissue density and tumor aggressiveness. Two independent research groups have found that simultaneous inhibition of two signaling pathways resulted in substantially enhanced antitumor effects in mouse models of prostate and breast cancer. In an accompany commentary, Steven Grant, at Virginia Commonwealth University Health Science Center, Richmond, discusses the clinical importance of these studies and highlights some of the questions that still need to be answered. A new study published on bmj.com argues that for older women, health related quality of life can be improved by hormone replacement therapy (HRT). The authors recommend that HRT guidelines should be revised with this most current evidence taken into consideration. Earlier studies have shown that HRT has the potential for general improvements in quality of life measures - how patients feel or function. Duke University chemists have patented an efficient technique for synthesizing a marine algae extract in sufficient quantities to now test its ability to inhibit the growth of cancerous cells while leaving normal cells unaffected. The researchers also deduced that this molecule -- called largazole -- acts on cells through the same chemical mechanism as other anti-cancer compounds on the market or in clinical trials. Seeking to improve on nature, scientists used a spice-based compound as a starting point and developed synthetic molecules that, in lab settings, are able to kill cancer cells and stop the cells from spreading. The researchers are combining organic chemistry, computer-aided design and molecular biology techniques in developing and testing pharmaceutical compounds that can fight breast and prostate cancer cells. ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that the first patient has been treated in a global Phase 3 clinical trial of IMC-1121B, its anti-vascular endothelial growth factor receptor-2 (VEGFR-2) IgG1 monoclonal antibody, in women with metastatic breast cancer. Advocates, including those for breast cancer patients, are concerned about their relationship with pharmaceutical company Genentech following Roche's bid for the company, the A decade-long Nebraska study that showed disparities in breast and cervical cancer screenings could have spurred changes that raised the percentage of women screened in the state. "Disparities in screening between racial and ethnic groups, even in a homogeneous state such as Nebraska, are a problem and by digging into some of the differences we were able to have an impact on breast and cervical cancer screening," said lead study author Shingairai Feresu, Ph.D. Women who survive breast cancer for at least five years after treatment have an 89% chance that they will not have a recurrence of the cancer after 10 years and an 81% chance after 15 years, according to a study published online Tuesday in the Journal of the National Cancer Institute, Research by scientists at the University of Sheffield suggests that the combination of zoledronic acid (a drug used to prevent bone loss) and chemotherapy agent doxorubicin could stop the growth of breast cancer tumours. Dr Alexis Willett, Policy Manager at Breakthrough Breast Cancer, says: "Breakthrough welcomes any research which investigates new uses for existing treatments to help benefit people with breast cancer. An article published in The Lancet Oncology reports that postmenopausal women with breast cancer who are on endocrine treatment are likely to experience arthralgia and arthritis (joint symptoms) if they previously have used hormone replacement therapy (HRT), received a hormone-receptor positive tumor diagnosis, undergone chemotherapy, received treatment with anastrozole versus tamoxifen, or been obese. Scientists in the UK and Finland have discovered that a new combination of the chemotherapy drug doxorubicin and the bone-protecting drug zoledronic acid, both of which are considerably cheaper than herceptin, stopped breast cancer tumors growing in mice. Experts suggest that since both drugs are already in use, and if the combination proves effective and safe in human clinical trials, it should not take as long for it to be available as a new treatment for patients. Breast cancer patients and their physicians may make more informed, long-term treatment decisions using risk assessment strategies to help determine probability of recurrence, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reported in the Aug. 12 online issue of the Journal of the National Cancer Institute. Breast cancer patients and their physicians may make more informed, long-term treatment decisions using risk assessment strategies to help determine probability of recurrence, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reported in the Aug. 12 online issue of the Journal of the National Cancer Institute. Famous names from the fashion, television, radio and music industries have come together to back Fashion Targets Breast Cancer® (FTBC) UK in an advertising campaign which subtly plays on the topic of celebrity charity endorsement. Natalie Imbruglia, Anna Friel, Alan Carr, Edith Bowman and Twiggy have been shot by acclaimed photographer Rankin wearing their FTBC T-shirts with pride for the campaign from leading charity Breakthrough Breast Cancer which aims to raise £1m. US researchers estimated that the risk of relapse for breast cancer patients who were cancer-free for five years after systemic therapy (chemotherapy, hormone therapy, or both, as well as surgery) was not negligible although it was probably lower than many people realized. Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) announced that patient screening and dosing has begun in a Phase II trial designed to evaluate the safety and efficacy of bavituximab in combination with chemotherapy in patients with advanced breast cancer. American Airlines, the world's largest airline, and Susan G. Komen for the Cure®, the world's largest breast cancer organization, announced an expanded partnership with the unveiling of two specially co-branded aircraft, an American Airlines Boeing 757 and an American Eagle Embraer 145, each incorporating the renowned vivid pink-ribbon motif. Geron Corporation (Nasdaq: GERN) announced the enrollment of the first patient in a clinical trial of its telomerase inhibitor drug, GRN163L, in locally recurrent or metastatic breast cancer. The primary objective of the Phase I/II, dose escalation study is to determine the safety, maximum tolerated dose (MTD) and objective response rate of GRN163L when administered intravenously in combination with a paclitaxel/bevacizumab regimen in this patient population. A new discovery may lead to more effective screening and treatment for patients with a difficult to recognize syndrome characterized by tumor-like growths and a high risk of developing specific cancers. The research, published by Cell Press in the August 7 issue of the American Journal of Human Genetics, is the first in over thirteen years to identify an alternate susceptibility gene for Cowden syndrome (CS) and related disorders. |
|
|
|
Breast Cancer Digest RELATED ARTICLES Lets Start Screening For Breast Health In the United States, American women are told to begin annual mammographic screening for breast cancer at the age of 40. Long before we've reached this age, we are advised to perform a monthly breast exam and see our doctors for a clinical breast exam (CBE) annually as well. Fourteen Simple Things You Can Do To Reduce Your Risk for Breast Cancer 1. Increase your consumption of fresh, organic fruits and vegetables. The Insidiousness of Breast Cancer and Its Current Treatment In our modern world, the benefits that today's manufacturing and agricultural activities have brought us is more than painfully offset by the damage to our personal health and wellness. During the course of our daily lives, we are continually exposed to common household products such as detergents, insulation, fabric treatments, flame retardants, cosmetics, paints, upholstery preservatives, and coatings for electronic equipment. Breast Cancer Detection Unit for the Home Detecting Breast Cancer early is a key step in protecting yourself from the dire consequences and risk of breast cancer. There is now some new technology using Infrared to help you do self-examinations in the privacy of your own home. Emotional Responses to Breast Cancer - Understanding the One You Love Being diagnosed with breast cancer is a life-changing event. A torrent of feelings wash over the survivor. Passive Smokers Can Get Breast Cancer! Learn How? US scientists have claimed that secondhand smokers are at higher risk of Breast Cancer. Earlier, their research also led to them to the conclusion that young women smokers are more likely to get addicted to smoking than young men. Early Detection And Breast Cancer It is generally accepted that by the time a cancer is found by mammography or palpated during a clinical breast exam, the cancer has been growing for 8-10 years. What if we could have been alerted to the problem as it was developing, rather than wait till it is large enough to be seen by the naked eye? Would that be of interest to you?There exists a technology that can detect an issue YEARS before a tumor can be seen on X-ray or palpated during an exam. Mammogram and Breast Cancer Screening Cancer screening The term screening is commonly used for a test that is used for evaluation of a person for possible disease without the person ever having any symptoms or signs of the disease. Screening tests are usually undertaken in a target population, which has significantly high risk of developing the disease. A Tool for Early Breast Cancer Screening Who isn't familiar with the expression, "early detection is the best prevention?" We hear this term throughout the year and most everyone is familiar with this "catch phrase" as it relates to breast cancer. Obviously, a woman's chance for survival improves when a cancer is found early. Breast Cancer In December of 2001, breast cancer was the furthest thing from my mind. I was busy. Can You Reduce Your Risk of Breast Cancer? We hear it all the time?lose weight for your health. Few people however, realize the extent to which this is critical to their physical well-being and ultimately their life expectancy. Mammograms Are No Joke - They Can Save Lives! There are so many jokes about mammograms! Have you heard the one about the fridge door ?or the bookends ?or the garage floor? Thanks to all the jokes, "Mammogram" has become a household word, and it's not that I don't have a sense of humor, but as a mammography technologist, I've heard the jokes many times. I think the jokes are embarrassing for women and demeaning with regard to their physical bodies. New Advances In Early Breast Cancer Detection In November 2003, the American Cancer Society stated that breast cancer is the leading cause of death in women between the ages of 40 and 44. In the United States, there are approximately 200,000 new cases of breast cancer and more than 40,000 deaths; making the U. Breast Cancer Statistics - How Breast Cancer Survival Rates Increased 50% Breast cancer statistics show that over 1.2 million persons will be diagnosed with breast cancer worldwide this year, according to the World Health Organization. Early Breast Cancer Detection Most women are familiar with mammography as our "gold standard" for breast cancer screening. However, there are additional tools available that women can add to their arsenal. Breast Cancer for Beginners Introduction Because of the social changes, which has brought increased number of workingwoman and hence delayed childbearing, there has been a steep rise in the number of breast cancer patients in the last few decades. But as the incidence of the patients has risen so has raised the modality of treatments and the success rates. Finding Your Spiritual Strength in the Midst of Your Emotional Turmoil There were so many emotions that I experienced in 2003 when the doctor confirmed I had Breast Cancer; I was overwhelmed. That was a point in my life that seemed to play out in slow motion. Breast Cancer The Cure You have my permission to publish this article electronically or in print, free of charge, as long as the bylines are included. A courtesy copy of your publication would be appreciated. Recommendations For Early Breast Cancer Screening Women need to empower themselves about the benefits and risks of mammography and examine the additional screening tools available today. One current philosophy suggests breast health screening should begin at age 25. Breast Cancer Awareness and Prevention Tips October is Breast Cancer Awareness month. Men and women can take preventative steps for avoiding breast cancer and staying healthy.
|
| home | site map| privacy policy |
| © 2008, Celerity Consultants, Mumbai, India, All Rights Reserved |